会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Inhibitors of caspases
    • 胱天蛋白酶抑制剂
    • US06426413B1
    • 2002-07-30
    • US09654855
    • 2000-09-05
    • Marion W. WannamakerPaul CharifsonDavid J. LaufferMichael D. Mullican
    • Marion W. WannamakerPaul CharifsonDavid J. LaufferMichael D. Mullican
    • C07D24302
    • C07D401/12C07D243/02C07D401/14C07D405/12
    • The present invention relates to novel classes of compounds which are caspase inhibitors, in particular interleukin-1&bgr; converting enzyme (“ICE”) inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting caspase activity and consequently, may be advantageously used as agents against interleukin-1-(“IL-1”), apoptosis-, interferon-&ggr; inducing factor-(IGIF), or interferon-&ggr;-(“IFN-&ggr;”) mediated diseases, including inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases. This invention also relates to methods for inhibiting caspase activity and decreasing IGIF production and IFN-&ggr; production and methods for treating interleukin-1, apoptosis-, and interferon-&ggr;-mediated diseases using the compounds and compositions of this invention. This invention also relates to methods of preparing the compounds of this invention.
    • 本发明涉及新型的化合物,其是胱天蛋白酶抑制剂,特别是白细胞介素-1β转换酶(“ICE”)抑制剂。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适用于抑制胱天蛋白酶活性,因此可有利地用作抗白细胞介素-1-(“IL-1”),细胞凋亡,干扰素-γ诱导因子(IGIF) 或“干扰素-γ”(“IFN-γ”)介导的疾病,包括炎性疾病,自身免疫性疾病,破坏性骨病,增殖性疾病,感染性疾病和退行性疾病。 本发明还涉及使用本发明的化合物和组合物来抑制胱天蛋白酶活性和降低IGIF产生和IFN-γ产生的方法以及用于治疗白介素-1,细胞凋亡和干扰素-γ介导的疾病的方法。 本发明还涉及制备本发明化合物的方法。